Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH Agonists: A Prospective, Observational, Phase IV Study (DELAY).
Phase of Trial: Phase IV
Latest Information Update: 26 Dec 2016
At a glance
- Drugs Degarelix (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms DELAY
- 10 Jun 2017 Biomarkers information updated
- 21 Dec 2016 Status changed from recruiting to completed.
- 07 Jun 2011 New trial record